GPT and neutropenia: Serious infection: treatment group (12%), control group (12%). ALT increase: treatment group (31.02%), control group (19%). Invasive bacterial or fungal infection: treatment group (6.9%), control group (4%). Grade ≥2 hypersensitivity reaction: treatment group (2.4%), control group (0%). Grade 4 neutropenia: treatment group (2.7%), control group (0)